Merete Paludan

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi request reprint Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
    Merete Paludan
    Department of Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 45:818-22. 2006
  2. doi request reprint Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy
    Else Stougård Andersen
    Department of Medical Physics, Aarhus University Hospital, Denmark
    Radiother Oncol 107:52-7. 2013
  3. doi request reprint Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    Radiother Oncol 93:402-7. 2009
  4. doi request reprint Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component
    Lars Fokdal
    Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 107:63-8. 2013
  5. doi request reprint Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
    Trine Lembrecht Jørgensen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Gynecol Oncol 127:367-74. 2012
  6. ncbi request reprint Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
    Pia Baumann
    Division of Oncology and Hospital Physics, Radiumhemmet Karolinska University Hospital, Sweden
    Acta Oncol 45:787-95. 2006

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
    Merete Paludan
    Department of Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 45:818-22. 2006
    ..Concern about pulmonary toxicity should not be prohibitive for future studies targeting limitations to dose and volume...
  2. doi request reprint Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy
    Else Stougård Andersen
    Department of Medical Physics, Aarhus University Hospital, Denmark
    Radiother Oncol 107:52-7. 2013
    ..The purpose of this study was to evaluate uncertainties associated with bladder dose accumulation based on DVH parameter addition (previously called "the worst case assumption") in fractionated BT...
  3. doi request reprint Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
    Neil Kopek
    Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark
    Radiother Oncol 93:402-7. 2009
    ..To determine the prognostic role of co-morbidity in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT)...
  4. doi request reprint Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component
    Lars Fokdal
    Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 107:63-8. 2013
    ....
  5. doi request reprint Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
    Trine Lembrecht Jørgensen
    Department of Oncology, Odense University Hospital, Odense, Denmark
    Gynecol Oncol 127:367-74. 2012
    ..Objectives of this study were to evaluate the significance of comorbidity and age ≥70 years on receiving cytoreductive surgery, standard combination chemotherapy (TC), adherence to TC treatment, and prognosis...
  6. ncbi request reprint Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
    Pia Baumann
    Division of Oncology and Hospital Physics, Radiumhemmet Karolinska University Hospital, Sweden
    Acta Oncol 45:787-95. 2006
    ..EQD2 (> v.s.<55.6 Gy) showed a statistically significant benefit survival for the higher doses. SBRT for stage I NSCLC results in favourable local control not inferior to fractionated RT and with acceptable toxicity...